| 000 | 01571 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515012104.0 | ||
| 264 | 0 | _c20060214 | |
| 008 | 200602s 0 0 eng d | ||
| 022 | _a0041-1345 | ||
| 024 | 7 |
_a10.1016/j.transproceed.2005.09.163 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMarzoa-Rivas, R | |
| 245 | 0 | 0 |
_aSafety of statins when response is carefully monitored: a study of 336 heart recipients. _h[electronic resource] |
| 260 |
_bTransplantation proceedings _cNov 2005 |
||
| 300 |
_a4071-3 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnticholesteremic Agents _xadverse effects |
| 650 | 0 | 4 | _aAtorvastatin |
| 650 | 0 | 4 | _aBody Mass Index |
| 650 | 0 | 4 |
_aGraft Rejection _xprevention & control |
| 650 | 0 | 4 |
_aHeart Transplantation _xpathology |
| 650 | 0 | 4 |
_aHeptanoic Acids _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aOverweight |
| 650 | 0 | 4 |
_aPravastatin _xtherapeutic use |
| 650 | 0 | 4 |
_aPyrroles _xtherapeutic use |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSafety |
| 700 | 1 | _aCrespo-Leiro, M G | |
| 700 | 1 | _aPaniagua-Marin, M J | |
| 700 | 1 | _aLlinares-García, D | |
| 700 | 1 | _aMuñiz-Garcia, J | |
| 700 | 1 | _aAldama-López, G | |
| 700 | 1 | _aPiñón-Esteban, P | |
| 700 | 1 | _aCampo-Pérez, R | |
| 700 | 1 | _aCastro-Beiras, A | |
| 773 | 0 |
_tTransplantation proceedings _gvol. 37 _gno. 9 _gp. 4071-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.transproceed.2005.09.163 _zAvailable from publisher's website |
| 999 |
_c16004818 _d16004818 |
||